Literature DB >> 16421435

Regulatory T cells: back to the future.

J Damoiseaux1.   

Abstract

Regulatory T cells seem to represent the resurrection of the old suppressor T cells. Although of a different phenotype, regulatory T cells are able to suppress many T cell mediated immune responses. While most basic knowledge about these cells is derived from animal studies, the recent identification of these cells in humans has further attributed to their characterisation by in vitro analysis. Results obtained have led to broad speculations about therapeutic potential by interference with these regulatory T cells. This review is an introduction to the world of regulatory T cells and contains an historical overview with respect to the identification and characterisation of these T cells. A distinction is made between naturally occurring regulatory T cells (nT(reg)), which require cell-cell contact for suppression, and inducible regulatory T cells (iT(reg)), which predominantly mediate suppression via cytokine dependent pathways. Although only limited studies on regulatory T cells in human disease are available today, the possible clinical applications are discussed in light of the other side of the coin, i.e. the danger of interfering with homeostatic mechanisms in the immune system.

Entities:  

Mesh:

Year:  2006        PMID: 16421435

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  6 in total

1.  Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study.

Authors:  Kim D G van de Kant; Ester M M Klaassen; Quirijn Jöbsis; Annedien J Nijhuis; Onno C P van Schayck; Edward Dompeling
Journal:  BMC Public Health       Date:  2009-06-29       Impact factor: 3.295

2.  Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets.

Authors:  Maria Nikolova; Jean-Daniel Lelievre; Matthieu Carriere; Armand Bensussan; Yves Lévy
Journal:  Blood       Date:  2009-02-25       Impact factor: 22.113

3.  CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients.

Authors:  Cinthya E Díaz-Benítez; Karla R Navarro-Fuentes; Jacqueline A Flores-Sosa; Janet Juárez-Díaz; Felipe J Uribe-Salas; Edgar Román-Basaure; Ludwig E González-Mena; Patricia Alonso de Ruíz; Guillermina López-Estrada; Alfredo Lagunas-Martínez; Victor H Bermúdez-Morales; Juan M Alcocer-González; Jesús Martínez-Barnetche; Rogelio Hernández-Pando; Yvonne Rosenstein; José Moreno; Vicente Madrid-Marina
Journal:  J Clin Immunol       Date:  2009-03-04       Impact factor: 8.317

4.  Influence of short-term glucocorticoid therapy on regulatory T cells in vivo.

Authors:  Silviu Sbiera; Thomas Dexneit; Sybille D Reichardt; Kai D Michel; Jens van den Brandt; Sebastian Schmull; Luitgard Kraus; Melanie Beyer; Robert Mlynski; Sebastian Wortmann; Bruno Allolio; Holger M Reichardt; Martin Fassnacht
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

Review 5.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

6.  Th17 immunity in children with allergic asthma and rhinitis: a pharmacological approach.

Authors:  Giusy Daniela Albano; Caterina Di Sano; Anna Bonanno; Loredana Riccobono; Rosalia Gagliardo; Pascal Chanez; Mark Gjomarkaj; Angela Marina Montalbano; Giulia Anzalone; Stefania La Grutta; Fabio Luigi Massimo Ricciardolo; Mirella Profita
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.